Drug Trial Radar · NCT07365995
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
736
Planned (sponsor's estimate)
Start
Apr 22, 2026
Primary completion
Feb 2031
Study completion Feb 2031
Sponsor
- Lead sponsor
- BioNTech SEIndustry
- Sponsor type
- Industry
- Collaborators
- BioNTech (Shanghai) Pharmaceuticals Co., Ltd.; DualityBio Inc.
- First posted
- Jan 26, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will test whether BNT324 is safe and works better against metastatic castration-resistant prostate cancer (mCRPC) than the current standard of care (SoC) chemotherapy, which is docetaxel (given together with the steroid medicines prednisone or prednisolone). The study will include participants with mCRPC that have been previously treated with androgen receptor pathway inhibitor, but with no previous taxane-based systematic chemotherapy for mCRPC. The main goals of this study are: * To find out if BNT324 helps participants live longer without their cancer getting worse (radiographic progression-free survival \[rPFS\]). * To find out if BNT324 helps participants live longer overall (overall survival \[OS\]).
Conditions
- Metastatic Castration-resistant Prostate Cancer
Interventions
BNT324Drug
Intravenous infusion
DocetaxelDrug
Intravenous infusion
Prednisone/prednisoloneDrug
Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- rPFS assessed by BICRTime frame: From randomization to end of study, i.e., up to 58 months
- OSTime frame: From randomization to end of study, i.e., up to 58 months
Locations
77 sites in 10 countries. Site status is shown where the registry gives one.
Del Sol Research Mgmt LLC
Tucson, Arizona · Recruiting
Sansum Clinic
Santa Barbara, California · Recruiting
Rocky Mountain Cancer Centers
Aurora, Colorado · Recruiting
Florida Cancer Specialists- Fort Myers
Fort Myers, Florida · Recruiting
Florida Cancer Specialists- St. Petersburg
St. Petersburg, Florida · Recruiting
Florida Cancer Specialists- West Palm Beach
West Palm Beach, Florida · Recruiting
Piedmont Cancer Institute
Atlanta, Georgia · Recruiting
Illinois Cancer Specialists
Niles, Illinois · Recruiting
Illinois CancerCare PC
Peoria, Illinois · Recruiting
Maryland Oncology Hematology
Rockville, Maryland · Recruiting
NYOH Albany Cancer Center
Albany, New York · Recruiting
White Plains Hospital
White Plains, New York · Recruiting
Oncology/Hematology Care, Inc.
Cincinnati, Ohio · Recruiting
START Carolinas
Myrtle Beach, South Carolina · Recruiting
SCRI Oncology Partners
Nashville, Tennessee · Recruiting
Tennessee Oncology
Nashville, Tennessee · Recruiting
Texas Oncology South Austin
Austin, Texas · Recruiting
Texas Oncology Gulf Coast
Houston, Texas · Recruiting
Texas Oncology, P.A. - Tyler
Tyler, Texas · Recruiting
Texas Oncology - West Texas
Wichita Falls, Texas · Recruiting
Virginia Cancer Specialists PC
Fairfax, Virginia · Recruiting
Virginia Oncology Associates
Norfolk, Virginia · Recruiting
Cancer Research SA
Adelaide, Australia · Recruiting
Box Hill Hospital
Box Hill, Australia · Recruiting
Austin Health
Heidelberg, Australia · Recruiting
Tasman Onco Research Pty Ltd
Southport, Australia · Recruiting
Cliniques Universitaires Saint-Luc
Brussels, Belgium · Recruiting
AZ Sint-Lucas Gent
Ghent, Belgium · Recruiting
Hospital Moinhos de Vento
Porto Alegre, Brazil · Recruiting
Peking University First Hospital
Beijing, China · Recruiting
Beijing Friendship Hospital, Capital Medical University
Beijing, China · Recruiting
Beijing Cancer Hospital
Beijing, China · Recruiting
The First Affiliated Hospital of Hunan Normal University
Changsha, China · Recruiting
West China Hospital, Sichuan University
Chengdu, China · Recruiting
Chongqing Univ. Cancer Hosp.
Chongqing, China · Recruiting
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, China · Recruiting
Fujian Medical University Union Hospital
Fuzhou, China · Recruiting
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China · Recruiting
Zhejiang Prov. People's Hosp.
Hangzhou, China · Recruiting
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Hangzhou, China · Recruiting
Showing 40 of 77 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.